Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06275815 · ClinicalTrials.gov registry record · NA

Promoting Caregiver Implementation of an Effective Early Learning Intervention

A NA study of Developmental Language Disorder and Reading; Difficult, sponsored by Ohio State University.

Recruiting
Registry status
NA
Development phase
320
Enrollment target
2
Study locations

NCT06275815: Recruiting NA study of Developmental Language Disorder and Reading; Difficult, sponsored by Ohio State University.

NCT06275815 is a NA study of Developmental Language Disorder and Reading; Difficult that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 320 participants, above the 164-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (95% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06275815, a NA study of Developmental Language Disorder and Reading; Difficult, is actively recruiting participants, sponsored by Ohio State University.

RECRUITING
Registry status
NA
Development phase
320 participants
Enrollment target
2
Study locations

Study Summary

The goal of this study is to examine the impact of a caregiver-implemented shared reading program, Sit Together and Read (STAR), on children ages 4 to 5 with developmental language disorder. The main questions it aims to answer are: * how much STAR impacts children's literacy skills in the short-term and long-term--up to two-years after completing STAR. * how do caregiver supports in the form of small monetary rewards or encouraging texts help caregivers to implement STAR at its intended frequency of sessions per week. Caregiver participants will be assigned to either a control group or one of three STAR groups. Children's skills related to literacy and learning will be assessed before the intervention starts, at the end of the intervention, and every six months post-intervention for two years. Researchers will determine the short term and long term impacts of STAR compared to the control group. Researchers will compare the three STAR conditions to see if the rewards or encouragement helped parents to follow through with completing more STAR sessions.

Primary Outcome

Standardized criterion-referenced measure of children's knowledge of 15 basic print concepts

Interventions

  • OTHER Sit Together and Read (STAR)
  • BEHAVIORAL Monetary Reward
  • BEHAVIORAL Text Encouragement

Study Locations (2)

Ohio

  • Schoenbaum Family Center; Crane Center for Early Childhood Research and Policy - Columbus
  • Nationwide Children's Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 320 participants
Start Date 2024-04-10
Est. Completion 2028-07-31
Phase NA
Ohio State University

552 total trials

What NCT06275815 shows while recruiting

NCT06275815 is an interventional study that assigns participants to a tested intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap, above the 164-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (95% higher).

The record links to 2 conditions, with Developmental Language Disorder appearing as the primary indexed condition, and to 3 interventions - of which Sit Together and Read (STAR) is the first listed.

NCT06275815 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06275815 about?

NCT06275815 is a clinical study titled "Promoting Caregiver Implementation of an Effective Early Learning Intervention". The goal of this study is to examine the impact of a caregiver-implemented shared reading program, Sit Together and Read (STAR), on children ages 4 to 5 with developmental language disorder. The main questions it aims to answer are: * how much STAR impacts children's literacy skills in the short-te...

What is the current status of trial NCT06275815?

This trial is currently recruiting. It is a NA study. The enrollment target is 320 participants. The study started on 2024-04-10. Estimated completion is 2028-07-31.

What conditions does trial NCT06275815 study?

This clinical trial studies the following conditions: Developmental Language Disorder, Reading; Difficult.

What interventions are being tested in trial NCT06275815?

The interventions under investigation include: Sit Together and Read (STAR) (OTHER), Monetary Reward (BEHAVIORAL), Text Encouragement (BEHAVIORAL).

Who is sponsoring clinical trial NCT06275815?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06275815 being conducted?

This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Developmental Language Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06275815's enrollment target sits among peer trials

320 5th of 17 higher than 13 of 17 other Developmental Language Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Developmental Language Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02763683 · 320 participants

    Investigations of Dementia in Parkinson Disease

  • NCT03331198 · 320 participants · Phase 1

    Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

  • NCT03458832 · 320 participants

    Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

  • NCT03551951 · 320 participants

    Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06275815, the US trial registry maintained by the National Library of Medicine. NCT06275815 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.